News
Novo Nordisk reports its results in Danish kroner (DKK) rather than U.S. dollars. Sales grew 19% year over year to 78.1 ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.
15h
TipRanks on MSNBavarian Nordic’s Earnings Call: Strong Growth and Positive OutlookBavarian Nordic A/S (($BVNRY)) has held its Q1 earnings call. Read on for the main highlights of the call. Bavarian Nordic’s recent earnings call ...
13h
TipRanks on MSNBavarian Nordic Reports Strong Q1 2025 GrowthBavarian Nordic A/S ( ($BVNRY) ) has released its Q1 earnings. Here is a breakdown of the information Bavarian Nordic A/S presented to its ...
Financial report for the period 1 January 2025 to 31 March 2025 Operating profit increased by 22% in Danish kroner and by 20% ...
Novo Nordisk Q1 sales missed estimates despite strong growth in Wegovy and Ozempic, prompting a cut to its 2025 guidance amid ...
The FDA in February formally declared the end of the semaglutide shortage, which Novo Nordisk expects will help improve the ...
P/F Atlantic Petroleum (NASDAQ OMX: ATLA DKK) today announces its Annual Results for 2024. This company announcement should ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.
Operating profit increased by 22% in Danish kroner and by 20% at constant exchange rates (CER) to DKK 38.8 billion. Sales in US Operations increased by 20% in Danish kroner (17% at CER).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results